Linda Beller Fanning, MSW, LCSW, ACSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2507 Christie Cr., Marylhurst, OR 97036 Phone: 503-635-3416 Fax: 503-697-6932 |
News Archive
Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuximab vedotin given before and after doxorubicin, vinblastine and dacarbazine chemotherapy, which is the standard of care.
Millions of children have surgery every year - for everything from tonsil removal to correction of a heart defect - and understandably parents are often anxious about their child's safety and comfort.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies today unveiled the CONCORDE LIFT Expandable Interbody Device to European Surgeons at the EUROSPINE 2018 Meeting, taking place in Barcelona, Spain.
The boom in cancer biomarker investments over the past 25 years has not translated into major clinical success. The reasons for biomarker failures include problems with study design and interpretation, as well as statistical deficiencies, according to an article published online August 12 in The Journal of the National Cancer Institute.
› Verified 3 days ago